贝伐珠单抗联合TP方案化疗对晚期子宫颈癌患者血清肿瘤标志物及不良反应的影响<sup>*</sup>

doi:10.3969/j.issn.1674-4985.2025.19.003

中国医学创新

2025, Vol. 22

Issue (19): 10-14 DOI: 10.3969/j.issn.1674-4985.2025.19.003

Article

Current Issue | Archive | Adv Search

The Influence of Bevacizumab Combined with TP Regimen Chemotherapy on Serum Tumor Markers and Adverse Reactions in Patients with Advanced Cervical Cancer

YAN Pingping, XIONG Xinghui

First-author's address: Department of Oncology, Fengcheng People's Hospital, Fengcheng 331100, China

Abstract
Figure/Table
References
Related Citation (15)